Contact Us

Use the form on the right to contact us.

You can edit the text in this area, and change where the contact form on the right submits to, by entering edit mode using the modes on the bottom right. 


123 Street Avenue, City Town, 99999

(123) 555-6789


You can set your address, phone number, email and site description in the settings tab.
Link to read me page with more information.

Understanding the drug Development process

Understanding the Drug Development/Review Process


  • 4/24/18 (10:00AM - 1:00PM EST and from 3:00PM - 6:00PM EST)  

Course Description:

  • Designed for life sciences professionals from all disciplines who require (or desire) a basic understanding of drug development from both an FDA and industry insider perspective. 
  • Targeted for numerous life science disciplines, including:
    • Clinical
    • Regulatory
    • Commercial
    • Medical
    • Legal
    • Compliance
    • Training
    • Medical writers
    • Communications
  • Utilizes a ‘backward planning’ perspective – focusing on drug development with maximum patient benefit and commercialization in mind.

Topics include, but are not limited to:

  • Drug Development phases and definition
  • IND and NDA (BLA)
  • FDA organizational structure – Centers, Offices, Divisions, etc
  • Working with FDA (meetings, preparation and follow-up, expectations, interpersonal interactions)
  • FDA internal interactions
  • FDA external interactions: other regulatory agencies, advisory committees, etc.
  • FDA Reviewer backgrounds and roles
  • PDUFA, FDAAA and other laws and their regulations
  • The importance of FDA Guidances to successful drug development
  • Utilizing the Targeted Product Profile to ensure maximal patient benefit, labeling, and commercialization.
  • Understanding review times and special review - implications and use (breakthrough, expedited, 505b2, accelerated approval – subpart H and E, fast track, etc.)
  • Action letters and responses – what do they mean?
  • Best practices of working with FDA during the drug development process
  • Understanding FDA’s thinking on substantial evidence standard vs. “emerging” categories of evidence like RWE and meta-analyses


To register please follow the two step process. First, fill out the registration form below and hit SUBMIT. Then click the PAY NOW button and follow the steps to pay and complete your registration. 

Name *
Terms and Agreement *
This program and all materials supporting the program are intended for educational purposes only. They are not intended to provide legal, regulatory or risk advice or guidance regarding any specific situation or scenario and are not a substitute for the advice of your advisors on specific issues. This material is based on the laws and regulations  and  DDMAC/OPDP/APLB enforcement letters in place at the time of the presentation and reflects the individual opinions of Lucy Rose and Associates, LLC.  Because regulations change and risk evaluation is a subjective matter, the information  and opinions provided and expressed  as part of the program should not be relied upon for decision-making purposes. Further, Lucy Rose and Associates, LLC does not warrant or guarantee that you or your employer or any of its employees or contractors, by relying on the educational materials provided by the program, would not be subject to regulatory or  legal enforcement actions. This material is copyrighted ; it or any part of it may not be photocopied, reproduced, disseminated ,or otherwise used by anyone other than Lucy Rose and Associates, LLC  without the express written prior authorization of  Lucy Rose and Associates, LLC.    Each individual paid registration is for one attendee. The program may not be shared with anyone other than a paid registrant either during its live presentation or in any recorded format. The program or any part of it may not be recorded or reproduced in any format including but not limited to: video, photographs, screen shots, audio recordings or by any other mechanism in existence now or in the future capable of reproducing or transmitting the program in whole or in part. Copyright 2017 by Lucy Rose and Associates, LLC.  All rights reserved.